Trileptal and Lentigo maligna stage unspecified - a phase IV clinical study of FDA data

Summary:

Lentigo maligna stage unspecified is reported only by a few people who take Trileptal.

The phase IV clinical study analyzes which people take Trileptal and have Lentigo maligna stage unspecified. It is created by eHealthMe based on reports of 20,849 people who have side effects while taking Trileptal from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

20,849 people reported to have side effects when taking Trileptal.
Among them, 4 people (0.02%) have Lentigo maligna stage unspecified.


What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 21,593 Trileptal users for its effectiveness, alternative drugs and more.

What is Lentigo maligna stage unspecified?

Lentigo maligna stage unspecified (colour forming cells cancer of in situ on skin unspecified) is found to be associated with 94 drugs and 43 conditions by eHealthMe.

Number of Trileptal and Lentigo maligna stage unspecified reports submitted per year:

Could Trileptal cause Lentigo maligna stage unspecified?

Gender of people who have Lentigo maligna stage unspecified when taking Trileptal *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Lentigo maligna stage unspecified when taking Trileptal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Trileptal *:

  1. Saw Palmetto: 1 person, 25.00%
  2. L-Lysine: 1 person, 25.00%
  3. Fish Oil: 1 person, 25.00%
  4. Aspirin: 1 person, 25.00%

Common side effects people have besides Lentigo maligna stage unspecified *:

  1. Rashes (redness): 4 people, 100.00%
  2. Stomatitis (inflammation of mucous membrane of mouth): 3 people, 75.00%
  3. Tongue Ulceration (ulcers on tongue): 1 person, 25.00%
  4. Mouth Ulcers: 1 person, 25.00%
  5. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 1 person, 25.00%
  6. Drowsiness: 1 person, 25.00%

Common conditions people have *:

  1. Complex Partial Seizures (epileptic seizure): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and have Lentigo maligna stage unspecified?

Check whether Lentigo maligna stage unspecified is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Lentigo maligna stage unspecified and when was it recovered:

Expand to all the drugs that have ingredients of oxcarbazepine:

Alternative drugs to, pros and cons of Trileptal:

Common Trileptal side effects:

Browse all side effects of Trileptal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lentigo maligna stage unspecified treatments and more:

COVID vaccines that are related to Lentigo maligna stage unspecified:

All the drugs that are associated with Lentigo maligna stage unspecified:

All the conditions that are associated with Lentigo maligna stage unspecified:

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Trileptal) and Trileptal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: